Michael Rohr

Representative transactions include:

Private

• Tectonic Therapeutic as primary outside counsel, including in its US$80 million Series A financing and merger with AVROBIO and simultaneous private placement of US$130.7 million.
• Alpheus Medical in its US$52 million Series B financing.
• Seismic Therapeutic in its US$101 million Series A financing and US$121 million Series B financing.
• Monolith Materials in its US$120 million Series C financing and US$300 million Series D financing.
• Gopuff in its US$1.15 billion private financing round.
• FIGUR8 in its US$25 million Series A-1 financing.
• General Catalyst in numerous investments, including:
  • Eleanor Health’s US$50 million Series C financing.
  • Series B investment in Index Systems.
• Zealand Pharma in its acquisition of Valeritas Holdings.
• automotiveMastermind in its US$45 million Series B financing and secondary tender offer.
• Brightree in its sale to ResMed for US$800 million.
• A unicorn technology company in its US$1 billion+ Series D financing, US$1.2 billion debt financing, and restructuring transaction.
• Frontline Technologies in its strategic acquisitions of multiple companies and sale to Roper Technologies for US$3.7 billion.
• Guidepost Growth Equity in its US$60 million Series B investment in Lucid Holdings and secondary tender offer.
• HighJump Software in its sale to Accellos (Accell-KKR) for US$237.5 million.
• Infraredx in its sale to Nipro Corporation.
• nToggle in its Series A financing, Series A-1 financing, and sale to Rubicon Project.
• Tarveda Therapeutics in its US$30 million Series D financings.
• Vesper Technologies in its US$18 million Series A financing and US$26 million Series B financing and acquisition by Qualcomm.
• InAuth in its Series A-1 financing with American Express.
• Avedro in its US$32 million recapitalization and Series AA financing, Series BB financing, and Series CC financing.
• The Cambridge Incubator (CIC) in its reorganization, and US$59 million Series A financing and US$80 million Series B financing.
• RxAdvance in its secondary investment and tender offer, joint venture, and subsequent Series A financing with Centene (CNC).
• CIMCON Lighting in its US$16 million Series B financing.
• Bessemer in its Series B investment in Toast.
• M33 Growth in multiple strategic growth equity investments/acquisitions, including Waterfield Energy Software, Titan Cloud Software, and AssuriCare.

Public

• Avedro in its US$70 million U.S. IPO.
• Biodel in its acquisition of Albireo.
• NetScout Systems acquisition of Danaher Corporation’s communications business unit for US$2.6 billion.
• Tectonic Therapeutic in its merger with AVROBIO and simultaneous private placement of US$130.7 million.

The above matters were handled prior to joining Sidley.